Centene Corporation

CNC

US15135B1017

Centene Corporation specializes in health services. Revenues break down by activity as follows: - development of health insurance programs (91%): primarily for children, pregnant women, blind and disabled persons; - specialized services (9%): pharmaceutical services (claims processing, pharmacy network management, mail order sales, home delivery, analysis and clinical consulting services, etc.), health care services by education and empowerment (behavioral orientation programs and welfare, nursing advice, etc.), eye and dental care services, home care services, development of health care management solutions, etc.

Sector

Managed Healthcare

Calendar

2024-07-26 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

INTERVIEW - Sarah London, CEO of Centene: How can we reduce healthcare costs?

June 27, 2023 at 04:45 pm EDT

More Strategies

Ratings for Centene Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

66.66 USD

Average target price

86.85 USD

Spread / Average Target

+30.29%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

	1st Jan change	Capi.
CENTENE CORPORATION	-9.38%	35.57B
ELEVANCE HEALTH, INC.	+13.20%	124B
CIGNA	+11.39%	93.72B
HUMANA INC.	-17.06%	45.69B
MOLINA HEALTHCARE, INC.	-19.72%	16.82B
PROGYNY, INC.	-24.21%	2.6B
ALIGNMENT HEALTHCARE, INC.	+2.32%	1.51B
CLOVER HEALTH INVESTMENTS, CORP.	+53.35%	665M

Other Managed Healthcare

Market Closed - Nyse Other stock markets 04:00:02 2024-07-11 pm EDT			5-day change	1st Jan Change
67.25 ^USD	+0.89%		+1.33%	-9.38%

Jul. 11	Jefferies Adjusts Price Target on Centene to $83 From $90	MT
Jul. 10	Centene Unit WellCare of North Carolina Earns Early Health Equity Accreditation	MT

Jefferies Adjusts Price Target on Centene to $83 From $90	Jul. 11	MT
Centene Unit WellCare of North Carolina Earns Early Health Equity Accreditation	Jul. 10	MT
JPMorgan Adjusts Price Target on Centene to $80 From $85	Jul. 10	MT
Centene Corporation(NYSE:CNC) dropped from Russell Top 200 Value Index	Jun. 30	CI
Centene Corporation(NYSE:CNC) dropped from Russell Top 200 Index	Jun. 30	CI
Centene Corporation(NYSE:CNC) added to Russell Midcap Value Index	Jun. 30	CI
Centene Corporation(NYSE:CNC) added to Russell Midcap Index	Jun. 30	CI
Barclays Adjusts Price Target on Centene to $90 From $104, Maintains Overweight Rating	Jun. 27	MT
Rate of US uninsured to rise to 8.9% in the next decade, Congressional Budget Office says	Jun. 18	RE
CMS to rework quality ratings for Medicare Advantage plans	Jun. 14	RE
Agilon Health Names Jeff Schwaneke CFO	Jun. 05	MT
Stephens Adjusts Price Target on Centene to $77 From $83	May. 31	MT
Transcript : Centene Corporation Presents at Bernstein?s 40th Annual Strategic Decisions Conference, May-31-2024 08:00 AM	May. 31
Baird Initiates Centene With Neutral Rating, $83 Price Target	May. 30	MT
US health insurer shares fall after UnitedHealth flags Medicaid medical use	May. 29	RE
Centene says Medicaid costs remain high in May	May. 29	RE
Centene sees higher-than-expected medical costs in Medicaid	May. 29	RE
Sector Update: Health Care Stocks Retreat Wednesday Afternoon	May. 29	MT
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues	May. 29	RE
Health Insurance Stocks Drop as UnitedHealth Flags 'Disturbance' in Medicaid	May. 29	MT
Declaration of Voting Results by Centene Corporation	May. 16	CI
Barclays Adjusts Price Target on Centene to $104 From $101	May. 02	MT
Bernstein Adjusts Centene's Price Target to $94 From $100	Apr. 30	MT
Deutsche Bank Adjusts Price Target on Centene to $82 From $81	Apr. 30	MT
Jefferies Adjusts Price Target on Centene to $90 From $94	Apr. 30	MT